Publications by authors named "Qinghong Fu"

Claim this Profile
M
Microscopic Investigation of Coupled Mobilization and Blending Behaviors Between Virgin and Reclaimed Aged Asphalt Mastic.
Jiaying Zhang, Xin Qiu, Qinghong Fu, Zheyu Shen, Xuanqi Huang

Materials (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Chloride Salt Erosion on Asphalt Binders and Mixtures: Performance Evaluation and Correlation Analysis.
Xin Qiu, Jianghui Deng, Qinghong Fu, Yunxi Lou, Yingci Ye

Materials (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores.
Shuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, Yang Yu, Zhicai Wu, Qinghong Fu

Bioorg Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Jiayi Xu, Songnian Lin, Robert W Myers, George Addona, Joel P Berger, Qinghong Fu

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.
Jiayi Xu, Songnian Lin, Robert W Myers, Maria E Trujillo, Michele J Pachanski, Qinghong Fu

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase.
James E Tarver, Theodore C Jessop, Marianne Carlsen, David J Augeri, Qinghong Fu

Bioorg Med Chem Lett· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.
Theodore C Jessop, James E Tarver, Marianne Carlsen, Amy Xu, Jason P Healy, Qinghong Fu

Bioorg Med Chem Lett· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
Jeffrey T Bagdanoff, Michael S Donoviel, Amr Nouraldeen, James Tarver, Qinghong Fu

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis